Conditional Regulatory T-Cell Depletion Releases Adaptive Immunity Preventing Carcinogenesis and Suppressing Established Tumor Growth
Open Access
- 13 October 2010
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (20), 7800-7809
- https://doi.org/10.1158/0008-5472.can-10-1681
Abstract
Foxp3 is a central control element in the development and function of regulatory T cells (Treg), and mice expressing a diphtheria toxin (DT) receptor–enhanced green fluorescent protein fusion protein under the control of the foxp3 gene locus (DEREG mice) allow conditional and efficient depletion of Foxp3+ Treg by DT injection. Herein, we use DEREG mice and a mouse model of carcinogenesis to show that conditional and effective Treg depletion can both protect mice from carcinogenesis by innate control, yet permanently eradicate a proportion of de novo–established tumors in mice in a largely CD8+ T-cell– and IFN-γ–dependent manner. Tumors displayed a heterogeneous response to Treg depletion, and suppression of established tumors was accompanied by an increase in the tumor-infiltrating CD8+ T-cell/B-cell ratio. Tumor rejection occurred in the absence of overt autoimmunity, suggesting that effective transient Treg depletion strategies may be therapeutic in at least a proportion of spontaneous tumors developing in the host. Cancer Res; 70(20); 7800–9. ©2010 AACR.Other Versions
This publication has 37 references indexed in Scilit:
- A Central Role for Foxp3+ Regulatory T Cells in K-Ras-Driven Lung TumorigenesisPLOS ONE, 2009
- DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumorsThe Journal of Experimental Medicine, 2008
- Accelerated tumor growth in mice deficient in DNAM-1 receptorThe Journal of Experimental Medicine, 2008
- Regulatory T cells and treatment of cancerCurrent Opinion in Immunology, 2008
- Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesisProceedings of the National Academy of Sciences of the United States of America, 2008
- The impact of regulatory T cells on carcinogen-induced sarcogenesisBritish Journal of Cancer, 2007
- Tregs and rethinking cancer immunotherapyJCI Insight, 2007
- Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like diseaseThe Journal of Experimental Medicine, 2007
- Foxp3-Expressing CD103+ Regulatory T Cells Accumulate in Dendritic Cell Aggregates of the Colonic Mucosa in Murine Transfer ColitisThe American Journal of Pathology, 2006
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006